VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,348,708 | -66.4% | 143,939 | -11.9% | 0.00% | – |
| Q2 2023 | $4,009,944 | -56.1% | 163,471 | -58.3% | 0.00% | -100.0% |
| Q1 2023 | $9,126,331 | +332.8% | 392,193 | +370.8% | 0.00% | – |
| Q4 2022 | $2,108,475 | -45.8% | 83,306 | -58.8% | 0.00% | -100.0% |
| Q3 2022 | $3,893,000 | +45.6% | 201,960 | +92.3% | 0.00% | – |
| Q2 2022 | $2,674,000 | -52.0% | 105,000 | -51.5% | 0.00% | -100.0% |
| Q1 2022 | $5,568,000 | -85.1% | 216,500 | -75.7% | 0.00% | -87.5% |
| Q4 2021 | $37,335,000 | +194.4% | 891,676 | +206.0% | 0.01% | +166.7% |
| Q3 2021 | $12,681,000 | +71.2% | 291,399 | +86.0% | 0.00% | +50.0% |
| Q2 2021 | $7,407,000 | -19.5% | 156,657 | -12.7% | 0.00% | 0.0% |
| Q1 2021 | $9,206,000 | +184.6% | 179,545 | +48.6% | 0.00% | – |
| Q4 2020 | $3,235,000 | -20.6% | 120,786 | +1.8% | 0.00% | -100.0% |
| Q3 2020 | $4,073,000 | -53.9% | 118,639 | -44.9% | 0.00% | -50.0% |
| Q2 2020 | $8,827,000 | +3532.5% | 215,429 | +1016.4% | 0.00% | – |
| Q4 2019 | $243,000 | – | 19,297 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |